Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections

被引:37
作者
Lins, H [1 ]
Wallesch, CW [1 ]
Wunderlich, MT [1 ]
机构
[1] Univ Magdeburg, Dept Neurol, D-39120 Magdeburg, Germany
来源
ACTA NEUROLOGICA SCANDINAVICA | 2005年 / 112卷 / 05期
关键词
cerebrospinal fluid; serum; neurochemistry; central nervous system infection; protein S100B; neuron-specific enolase;
D O I
10.1111/j.1600-0404.2005.00484.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - To elucidate the relation between release patterns and cerebrospinal fluid/serum concentrations of neurobiochemical markers of cerebral damage and their potential value as monitoring parameters in central nervous system infections. Methods - We investigated protein S-100B and neuron-specific enolase (NSE) in 102 sequential cerebrospinal fluid (CSF)-serum-pairs in patients with bacterial (n = 11) or viral (n = 13) meningitis/meningoencephalitis and neuroborreliosis (n = 8) in comparison with controls (n = 13). Results - Highest S-100B values in CSF and serum were found on admission and showed a significant decrease afterwards. Comparison between disease groups revealed significant differences between bacterial and viral meningitis and neuroborreliosis for S-100B and also when compared with controls. NSE was not significantly elevated. Conclusions - S-100B is altered in CNS infection but does not provide additional benefit in the differential diagnosis when compared with standard CSF parameters. Nevertheless, S-100B values might be used as an additional monitoring parameter especially when sequential lumbar punctures are contraindicated.
引用
收藏
页码:303 / 308
页数:6
相关论文
共 22 条
[11]   S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke [J].
Missler, U ;
Wiesmann, M ;
Friedrich, C ;
Kaps, M .
STROKE, 1997, 28 (10) :1956-1960
[12]  
Nygaard O, 1997, CLIN CHEM, V43, P541
[13]   Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level [J].
Oh, SH ;
Lee, JG ;
Na, SJ ;
Park, JH ;
Choi, YC ;
Kim, WJ .
ARCHIVES OF NEUROLOGY, 2003, 60 (01) :37-41
[14]   Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum:: prospective case-control study [J].
Otto, M ;
Wiltfang, J ;
Schütz, E ;
Zerr, I ;
Otto, A ;
Pfahlberg, A ;
Gefeller, O ;
Uhr, M ;
Giese, A ;
Weber, T ;
Kretzschmar, HA ;
Poser, S .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7131) :577-582
[15]   Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern [J].
Petzold, A ;
Keir, G ;
Lim, D ;
Smith, M ;
Thompson, EJ .
BRAIN RESEARCH BULLETIN, 2003, 61 (03) :281-285
[16]  
Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159
[17]  
Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79
[18]  
TEASDALE G, 1974, LANCET, V2, P81
[19]   Serum S100B levels in patients with cerebral and extracerebral infectious disease [J].
Undén, J ;
Christensson, B ;
Bellner, J ;
Alling, C ;
Romner, B .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (01) :10-13
[20]  
VANENGELEN BGM, 1992, CLIN CHEM, V38, P813